Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries

Primer Autor
Mente, Andrew
Co-autores
Bhavadharini, Balaji
Dehghan, Mahshid
Rangarajan, Sumathy
Sheridan, Patrick
Mohan, Viswanathan
Iqbal, Romaina
Gupta, Rajeev
Lear, Scott
Wentzel-Viljoen, Edelweiss
Avezum, Alvaro
Lopez-Jaramillo, Patricio
Mony, Prem
Varma, Ravi Prasad
Kumar, Rajesh
Chifamba, Jephat
Alhabib, Khalid F.
Mohammadifard, Noushin
Oguz, Aytekin
Lanas, Fernando
Rozanska, Dorota
Bostrom, Kristina Bengtsson
Yusoff, Khalid
Tsolkile, Lungiswa P.
Dans, Antonio
Yusufali, Afzalhussein
Orlandini, Andres
Poirier, Paul
Khatib, Rasha
Hu, Bo
Wei, Li
Yin, Lu
Deeraili, Ai
Yeates, Karen
Yusuf, Rita
Ismail, Noorhassim
Mozaffarian, Dariush
Teo, Koon
Anand, Sonia S.
Yusuf, Salim
Título
Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries
Editorial
BMJ PUBLISHING GROUP
Revista
BMJ OPEN DIABETES RESEARCH & CARE
Lenguaje
en
Tipo de Recurso
artículo original
Derecho de Acceso
acceso abierto
Description
The study was mainly funded by the Population Health Research Institute (PHRI). SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator--initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long--Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi--Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries.These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: this study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de la Frontera, China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100--IRDC/BIOTEK 16/6/21 (13/2007), and 07-05--IFN--BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 (2/2011)), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant number: 290/W--PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr. Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG -1436-013), South Africa: The North--West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.
doi
10.1136/bmjdrc-2019-000826
Formato Recurso
pdf
Palabras Claves
nutrition
hypertension
endocrinology
adult diabetes
Ubicación del archivo
Categoría OCDE
Endocrinología y Metabolismo
Materias
nutrición
hipertensión
endocrinología
diabetes en adultos
Disciplinas de la OCDE
Endocrinología y Metabolismo (Incluye Diabetes, Hormonas)
Id de Web of Science
WOS:000548921800001
Access Rights
acceso abierto
Derechos de acceso
acceso abierto
Formato
pdf
Título de la cita (Recomendado-único)
Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries
Identificador del recurso (Mandatado-único)
artículo original
Versión del recurso (Recomendado-único)
version publicada
Editorial
BMJ PUBLISHING GROUP
Revista/Libro
BMJ OPEN DIABETES RESEARCH & CARE
Categoría WOS
Endocrinología y Metabolismo
Idioma
en
Descripción
The study was mainly funded by the Population Health Research Institute (PHRI). SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator--initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long--Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi--Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries.These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: this study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de la Frontera, China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100--IRDC/BIOTEK 16/6/21 (13/2007), and 07-05--IFN--BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 (2/2011)), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant number: 290/W--PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr. Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group number: RG -1436-013), South Africa: The North--West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.
Referencia del Financiador (Mandatado si es aplicable-repetible)
PHRI
Heart and Stroke Foundation of Ontario
HHSRI
CIHR
Ontario Ministry of Health and Long-Term Care
AstraZeneca (Canada)
Sanofi-Aventis (France)
Sanofi-Aventis (Canada)
Boehringer Ingelheim (Germany)
Boehringer Ingelheim (Canada)
Servier
GlaxoSmithKline
Dairy Farmers of Canada
National Dairy Council (US)
Public Health Agency of Canada
Champlain Cardiovascular Disease Prevention Network
UFRO
National Center for Cardiovascular Diseases
ThinkTank Research Center for Health Development
ColCiencias 6566-04-18062
ColCiencias 6517-777-58228
Indian Council of Medical Research
MOSTI 100-IRDC/BIOTEK 16/6/21 (13/2007), 07-05-IFN-BPH 010
MOHE 600-RMI/LRGS/5/3 (2/2011)
Universiti Teknologi MARA
Universiti Kebangsaan Malaysia UKM-Hejim-Komuniti-15-2010
Polish Ministry of Science and Higher Education, Wroclaw Medical University 290/W--PURE/2008/0
Deanship of Scientific Research at King Saud University, Riyadh RG -1436-013
Swedish Heart and Lung Foundation
Swedish Research Council
Swedish Council for Health, Working Life and Welfare
King Gustaf V:s and Queen Victoria Freemason's Foundation
AFA Insurance
Tipo de ruta
dorada
verde
Revisa las metricas alternativas de Almetrics
Revisa las citaciones de Dimensions